American International Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-65,341
Closed -$351K 1263
2024
Q1
$351K Sell
65,341
-561
-0.9% -$3.01K ﹤0.01% 1843
2023
Q4
$331K Buy
65,902
+9,043
+16% +$45.4K ﹤0.01% 1888
2023
Q3
$96.1K Buy
56,859
+3,795
+7% +$6.41K ﹤0.01% 2537
2023
Q2
$148K Buy
53,064
+13,557
+34% +$37.7K ﹤0.01% 2343
2023
Q1
$71.9K Buy
39,507
+786
+2% +$1.43K ﹤0.01% 2603
2022
Q4
$196K Sell
38,721
-141
-0.4% -$715 ﹤0.01% 2135
2022
Q3
$193K Buy
38,862
+548
+1% +$2.72K ﹤0.01% 2178
2022
Q2
$143K Buy
38,314
+3,831
+11% +$14.3K ﹤0.01% 2385
2022
Q1
$193K Sell
34,483
-1,811
-5% -$10.1K ﹤0.01% 2260
2021
Q4
$221K Sell
36,294
-1,085
-3% -$6.61K ﹤0.01% 2308
2021
Q3
$364K Sell
37,379
-96
-0.3% -$935 ﹤0.01% 2053
2021
Q2
$535 Buy
37,475
+19,104
+104% +$273 ﹤0.01% 1880
2021
Q1
$436 Buy
18,371
+48
+0.3% +$1 ﹤0.01% 1908
2020
Q4
$244 Sell
18,323
-525
-3% -$7 ﹤0.01% 2178
2020
Q3
$131K Buy
18,848
+1,263
+7% +$8.78K ﹤0.01% 2375
2020
Q2
$216K Buy
+17,585
New +$216K ﹤0.01% 2073
2019
Q2
Sell
-17,983
Closed -$28K 3132
2019
Q1
$28K Sell
17,983
-584
-3% -$909 ﹤0.01% 2966
2018
Q4
$22K Sell
18,567
-143
-0.8% -$169 ﹤0.01% 3016
2018
Q3
$69K Buy
18,710
+597
+3% +$2.2K ﹤0.01% 2981
2018
Q2
$55K Sell
18,113
-769
-4% -$2.34K ﹤0.01% 2972
2018
Q1
$73K Sell
18,882
-1,015
-5% -$3.92K ﹤0.01% 2797
2017
Q4
$89K Sell
19,897
-580
-3% -$2.59K ﹤0.01% 2780
2017
Q3
$112K Buy
20,477
+1,532
+8% +$8.38K ﹤0.01% 2608
2017
Q2
$144K Buy
18,945
+8,671
+84% +$65.9K ﹤0.01% 2483
2017
Q1
$36K Buy
10,274
+688
+7% +$2.41K ﹤0.01% 2899
2016
Q4
$55K Sell
9,586
-25
-0.3% -$143 ﹤0.01% 2834
2016
Q3
$74.8K Buy
9,611
+14
+0.1% +$109 ﹤0.01% 2770
2016
Q2
$59.7K Buy
9,597
+5,725
+148% +$35.6K ﹤0.01% 2899
2016
Q1
$32K Buy
3,872
+2,872
+287% +$23.7K ﹤0.01% 4102
2015
Q4
$17K Hold
1,000
﹤0.01% 4336
2015
Q3
$11K Buy
+1,000
New +$11K ﹤0.01% 4469